combination of Trilaciclib and Pemetrexed

Phase 2Small molecule

JJiangsu Province Nanjing Brain Hospital

combination of Trilaciclib and Pemetrexed is one of 26 small molecule programs targeting Leptomeningeal Metastasis. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Leptomeningeal MetastasisActive, not recruiting

Leptomeningeal MetastasisPhase 2

Active, not recruiting

Competition

Competitive Landscape

34 competitors in Leptomeningeal Metastasis

#DrugCompanyPhaseTrials

Trexall

Alnylam Pharmaceuticals

Cytosar

Lenvima

Intrathecal Chemotherapy

PPrincess Maxima Center for Pediatric Oncology

Approved

1 5

Alimta

EEagle Vision Pharmaceutical Corp.

Phase 2

10 6

Folvite

Eli Lilly

Phase 2

1 7

Beyfortus

Keytruda

Decadron

AAspen Global Incorporated

Phase 2

2 10

Tuoyi

SSun Yat-sen University

Phase 2

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Leptomeningeal Metastasis1 trial

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis

Recruiting·JJiangsu Province Nanjing Brain Hospital·Phase 2·NCT06332287·25 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for combination of Trilaciclib and Pemetrexed. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — combination of Trilaciclib and Pemetrexed compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for combination of Trilaciclib and Pemetrexed. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Jiangsu Province Nanjing Brain Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: JJiangsu Province Nanjing Brain Hospital

combination of Trilaciclib and Pemetrexed

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Leptomeningeal Metastasis1 trial

References

Drug Info

Quick Facts

Related News